BANF1P3

Across TCGA pan-cancer cohorts, BANF1P3 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated BANF1P3 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher BANF1P3 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated BANF1P3 expression acts as an unfavorable survival marker, although some lineages such as CESC and READ show a favorable association.

MESO, ACC, and KICH are the cancer types where BANF1P3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Median	III,IV	0.421	0.699	<.001	120	view →
ACC	DFS	Median	All	0.237	0.631	<.001	102	view →
KICH	DFS	Median	III,IV	0.262	0.942	<.001	93	view →
CESC	DFS	Median	II,III,IV	0.668	0.232	<.001	58	view →
READ	DFS	Quartile	II,III,IV	0.853	0.493	<.001	44	view →
LUSC	OS	Tertile	All	0.733	0.583	.001	35	view →
SKCM	OS	Quartile	III,IV	0.932	0.775	.002	25	view →
LUAD	OS	Quartile	III,IV	0.301	0.735	.003	23	view →
LGG	DFS	Tertile	All	0.770	0.886	.001	21	view →
LIHC	OS	Tertile	II,III,IV	0.380	0.765	.001	20	view →
THCA	DFS	Median	All	0.958	0.910	.011	12	view →
UCEC	DFS	Quartile	All	0.660	0.826	.010	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

BANF1P3–MESO (OS)

Open the MESO breakdown →